课题基金 / 基金详情

Production Assistance for Cellular Therapies (PACT)- Cell Processing Facilities Cell manufacturing and process development services for PCT0031-02: GMP Production of iPSC Line and Scale-up of Cardiac

Production Assistance for Cellular Therapies (PACT)- Cell Processing Facilities Cell manufacturing and process development services for PCT0031-02: GMP Production of iPSC Line and Scale-up of Cardiac
细胞疗法生产协助 (PACT) - 细胞加工设施 PCT0031-02 的细胞制造和工艺开发服务:iPSC 生产线的 GMP 生产和心脏的放大
批准号:
10090766
负责人:
Joshua M Hare
金额:
$101.72万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-12-10 至 2021-08-09

项目摘要

项目成果

Joshua M Hare的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purpose of this task order to provide cell manufacturing services to an approved PACT program requestor. Dr. Hare's CPF will provide clinical grade Cardiac progenitor cells and exosomes to the requestor, Dr. Ashraf. The project has undergone scientific merit review by an external, peer review board and administrative review by NHLBI PACT project/program officers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Full-scale GMP Production for a Pre-Clinical Systemic Delivered Mesenchymal Stem Cells Derived Extracellular Vesicles For Cardiovascular Disease
1/2 Allogeneic Human Mesenchymal Stem Cell (MSC) Injection in Patients with Hypoplastic Left Heart Syndrome: A Phase IIb Clinical Trial
1/2 Allogeneic Human Mesenchymal Stem Cell (MSC) Injection in Patients with Hypoplastic Left Heart Syndrome: A Phase IIb Clinical Trial
A Phase 2b Clinical Trial to Study the Efficacy of Longeveron Mesenchymal Stem Cells (LMSCs) to Treat Aging Frailty
  • 批准号:
    9922198
  • 项目类别:
  • 资助金额:
    $197.43万
  • 财政年份:
    2018
  • 负责人:
    Joshua M Hare
  • 依托单位:
海外基金